Skip to main content
Equibles

SMNR · Semnur Pharmaceuticals, Inc. · Webcasts, Transcripts & Audio

Track SMNR — free

Use SMNR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SMNR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.45 -0.12 (-21.05%) At close · Oct 2
Rebalance outlook locked
Going-concern doubt — flagged Aug 10, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As a result, management has concluded that the aforementioned conditions, among other things, raise substantial doubt about the Company's ability to continue as a going concern for one year after the date the condensed consolidated financial statements are issued.”
View the 10-Q filed Aug 10, 2026
Market Cap
$137.90M
Shares
230.21M
Volume · Oct 2 3553 Avg daily vol (3M) 10.01K

Semnur Pharmaceuticals, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Semnur Pharmaceuticals, Inc. (SMNR), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

No Webcasts Available

No webcast events are available for this stock yet.

Key facts CIK 1913577 CUSIP 81686G105 Visit website Investor relations